Company / Assets per Share
AXIM BIOTECHNOLOGIES, INC. Assets per Share History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.02
FY2023
5-year range
$0.02 / $0.04
FY2019-FY2023
Trend
-29.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 3 consecutive years, from $0.04 in FY2017 to $0.02 in FY2023.
Based on SEC 10-K filings.
0.02 in FY2023 with a 10-year CAGR of +28.7%.
Declined from $0.04 to $0.02 over the past 5 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -11.0%
- 10-Year CAGR
- +28.7%
Key checks
Key Insights
- AXIM BIOTECHNOLOGIES, INC.'s assets per share has declined for 3 consecutive years.
- In FY2023, assets per share decreased 29.8% year-over-year.
- Peak assets per share was recorded in FY2017.
- Lowest assets per share in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.02 | -29.8% |
| FY2022 | $0.03 | -20.3% |
| FY2018 | $0.04 | -8.3% |
| FY2017 | $0.04 | +14.2% |
| FY2016 | $0.04 | -4.4% |
| FY2015 | $0.04 | +2120.2% |
| FY2013 | $0.00 | -57.2% |
| FY2012 | $0.00 | -41.4% |
| FY2011 | $0.01 | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026